Liupao tea, a drink homologous to medicine and food. It can treat dysentery, relieve heat, remove dampness, and regulate the intestines and stomach. The objective of this study is to explore the material basis and mechanism of Liupao tea intervention in COVID-19 and to provide a new prevention and treatment programme for COVID-19.We used high performance liquid chromatography to analyze the extract of Liupao tea and establish its fingerprint. The main index components of the fingerprint were determined using SARS-COV-2 3-chymotrypsin-like protease (3CL pro ), and an in vitro drug screening model based on fluorescence resonance energy transfer was used to evaluate its inhibitory activity in vitro. The fingerprint results showed that the alcohol extract of Liupao tea contained gallic acid, epigallocatechin gallate (EGCG), caffeine, epicatechin gallate, rutin, and ellagic acid. The molecular docking binding energies of the six index components of SARS-CoV-2 3Cl pro were all less than −5.0 kJ/mol and showed strong binding affinity. The results of in vitro activity showed that the IC 50 of EGCG was 8.84 μmol/L, which could inhibit SARS-CoV-2 3Cl pro to a certain extent. This study unleashed that EGCG has a certain inhibitory effect on SARS-CoV-2 3CL pro , and Liupao tea has a certain significance as a tea drink for the prevention of COVID-19. Practical applicationsThe objective of this study was to explore the material basis and mechanism of Liupao tea intervention in COVID-19 and to provide a new prevention and treatment programme for COVID-19. The molecular docking binding energies of the six index components of Liupao tea with SARS-CoV-2 3CL pro were all less than −5.0 kJ/mol, among them, the enzyme activity experiment shows that EGCG has a certain inhibitory effect on SARS-CoV-2 3CL pro , it can be used as a potential SARS-CoV-2 3CL pro How to cite this article: Ni W-J, Chen X-X, Wei S-Y, et al. Study on the mechanism of active components of Liupao tea on 3CL pro based on HPLC-DAD fingerprint and molecular docking technique.

The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos.

Aurantio‐obtusin (AUR) is the main bioactive compound among the anthraquinones, from Cassia seed extract. This study was conducted to identify whether AUR could improve obesity and insulin resistance, induced by a high‐fat diet in obese mice. Mice were fed a high‐fat diet for 6 weeks and were then assigned to the high‐fat diet (HFD) control group, the AUR 5 mg/kg group, or the AUR 10 mg/kg group. AUR improves glucose by activating the expression of PI3K, Akt and GLUT4, GLUT2. AUR altered the expression levels of several lipid metabolism‐related and adipokine genes. AUR decreased the mRNA expression of PPAR‐γ, FAS and increased the mRNA expression of PPAR‐α in liver. AUR lowered SREBP‐1c, FAS, SCD‐1, inflammatory cytokines, and increased the expression of PPAR‐γ, PPAR‐α, CPT‐1, and adiponectin in white adipose tissue (WAT). AUR docking with the insulin receptor showed that the residues of the insulin receptor, ectodomain, were the same as those around the emodin. The effect of AUR may be elicited by regulating the activity of the insulin signaling pathway, expression of lipid metabolism‐related genes, and expression of inflammatory cytokine markers to improve adiposity, insulin resistance, and dyslipidemia.

No abstract